EcoDrugPlus

Ensembl ID : ENSCHYG00000015264
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSCHYG00000011576
Gene Symbol: -
Cross references: -
399 Possible Orthologues:

Ensembl ID : ENSCHYG00000007473
Gene Symbol: -
Cross references: -
404 Possible Orthologues:

Ensembl ID : ENSCHYG00000007145
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSCHYG00000007072
Gene Symbol: -
Cross references: -
284 Possible Orthologues:

Ensembl ID : ENSCHYG00000002093
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCHYG00000001972
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSCHYG00000024890
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSCHYG00000014488
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSCHYG00000011339
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSCHYG00000007303
Gene Symbol: -
Cross references: -
296 Possible Orthologues:

Ensembl ID : ENSCHYG00000004500
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).